On Friday, Shares of Koninklijke Philips NV (ADR) (NYSE:PHG), gained 1.53% to $27.29.
Strengthening its leadership in connected healthcare informatics, Royal Philips (NYSE: PHG, AEX: PHIA), declared IntelliSpace Portal 8.0, the latest edition of its advanced data sharing, analytics and visualization platform that assists radiologists detect, diagnose and follow-up on treatment of diseases. Introduced at the 2015 Radiological Society of North America Annual Meeting (RSNA) in Chicago, IL, IntelliSpace Portal 8.0 assists address the changing demands in radiology that result from an increasing prevalence of cancer and its economic toll. It delivers new applications – like fast 3-D quantitative renderings of tumors – in a fully integrated oncology suite to improve diagnostic confidence and patient care.
The oncology suite complements the width and depth of applications that IntelliSpace Portal already offers as a comprehensive, advanced analysis platform. The portal assists clinicians visualize, diagnose, measure disease states and communicate across modalities, with one efficient, automated, and guided workflow. The latest release now boasts more than 68 clinical applications for 7 modalities counting CT, MR, Ultrasound, Mammography and iXR.
Koninklijke Philips N.V. engages in healthcare, consumer lifestyle, and lighting businesses worldwide. It provides various integrated clinical solutions, counting radiation oncology and portfolio administration; computed tomography, magnetic resonance imaging, and molecular imaging products; digital X-ray and mammography products; interventional X-ray products in cardiology, radiology, surgery, and other areas; and ultrasound products.
Shares of UniPixel Inc (NASDAQ:UNXL), declined -3.36% to $0.710, during its last trading session.
Uni Pixel, declared that it reached subscription agreements with investors for the sale of 9,625,871 units (“Units”) at a public offering price of $0.85 per Unit in a public offering resulting in predictable gross proceeds to the Company of $8.1 million (the “Offering”).
Each Unit comprises of one share of Uni Pixel common stock, par value $0.001 per share (“Common Stock”) and one warrant to purchase one share of Common Stock at an exercise price of $1.50 per share, exercisable for a period of five years from the date of the closing of the Offering.
Roth Capital Partners, LLC acted as lead placement agent in the Offering, with Ladenburg Thalmann & Co. Inc. serving as co-placement agent under the terms of a placement agency agreement reached with Roth Capital Partners.
The Offering is predictable to close on or priority to November 30, 2015, subject to satisfaction of customary closing conditions. The warrants will not be separately listed for trading.
Uni-Pixel, Inc., a pre-production stage company, engages in developing performance engineered film (PEF) products for the display, touch screen, and flexible electronics market segments in the United States.
Finally, Shares of Hologic, Inc. (NASDAQ:HOLX), ended its last trade with 0.30% gain, and closed at $40.06.
Hologic, declared that the Company will present at the 27th Annual Piper Jaffray Healthcare Conference in New York on Wednesday, December 2 at noon Eastern Time.
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health.
